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A35-year-old woman with a medical history of hered-itary and recurrent epistaxis and lip telangiectasia wasadmitted with sudden left thoracic pain and dyspnea.There was no recent history of fever or thoracic
trauma. Biologic data were as follows: hemoglobin level, 8.8 g/L;
hematocrit level, 28%; oxygen saturation, 97%; and fraction of
inspired oxygen, 10 L/min. Chest radiography and computed to-
mographic (CT) scanning revealed a left hemothorax with a sus-
picion of a vascular malformation in the left lower lobe (Figure 1).
There were no aortic or pericardial abnormalities.
An intercostal drain was placed in the left pleural cavity, and
2000 mL of blood was drained, leading to a significant clinical
improvement. Pulmonary angiography confirmed the presence of 2
arteriovenous fistulas in the upper part of the left lower lung and in
the lingula (Figure 2). Rendu-Osler-Weber syndrome (ROW) was
diagnosed on the basis of the patient’s history and clinical and
radiologic data.
Embolization of the lower lobe fistula was performed during
general anesthesia with 3 Guglielmi Detachable Coils (Boston
Scientific, Target Therapeutics, Fremont, Calif). One 3-dimen-
sional shaped coil of 8 20 mm and 2 fibered coils of 6 20 mm
and 4  20 mm, respectively, were placed with a 0.018-inch
microcatheter (Boston Scientific, Target Therapeutics) in the feed-
ing artery. Occlusion was completed with the injection of 0.3 mL
of enbucrilate (Histoacryl; Braun Aesculap, Tuttlingen, Germany)
emulsified with iodized oil (Lipiodol; Guerbet, Aulnay-sous-Bois,
France). Catheterization of the lingula fistula was technically more
difficult, and occlusion was achieved with a 4  20–mm fibered
spiral placed with a 0.018-inch microcatheter (Boston Scientific;
Figure 3).
Immediately after the endovascular procedure, video-assisted
thoracoscopic surgery was performed to remove any residual clot
and exclude further bleeding. The patient was placed in the right
decubitus position. A single-lumen endotracheal tube was inserted,
and ventilation was performed with reduced tidal volume through-
out the procedure. A 10-mm trocar was introduced through a skin
incision into the fifth intercostal space in the midaxillary line for
insertion of a 0° endoscope (Karl Storz, Tuttlingen, Germany).
Numerous clots and a large hemothorax in the left thoracic cavity
were observed. Two additional ports were then inserted under
direct vision. After the entire thoracic cavity had been rinsed with
saline and clots had been removed, pulmonary arteriovenous fis-
tulas were visible on the surface of the lung (Figure 4). No active
bleeding was observed, and no further operations were required.
Two 28F chest drains were introduced through the trocar incisions,
one in the eighth and one in the anterior fifth intercostal spaces.
The tubes were connected to an underwater seal suction device
(Pleurevac; Genzime, Cergy-Pontoise, France) with a negative
pressure of 20 cm H2O.
The patient was extubated 3 hours after the operation, and pain
was managed with a patient-controlled analgesia pump. Intercostal
drainage was continued for 4 days, with a total volume of 975 mL.
No air leak was observed, and the postoperative hospital stay was
6 days.
Follow-up angiography at 1 month and CT scanning at 3
months revealed recurrent limited flow in the lingula fistula (Fig-
ure 5). Repeat embolization was performed with 2 coils (1 fibered
coil of 2  50 mm and 1 coil of 2  30 mm) placed with a
0.018-inch microcatheter (Boston Scientific). The occlusion was
completed without injection of enbucrilate. Follow-up CT scans at
3 months and 2 years showed no recurrence.
Discussion
Rupture of pulmonary arteriovenous malformations (PAVMs) is a
rare life-threatening complication. Puskas and colleagues1 did not
observe any hemothorax in 21 patients treated between 1964 and
1992. Ference and coworkers2 reported only 5 (3.5%) patients with
spontaneous hemothorax and 6 with massive hemoptysis in a study
of 143 patients with PAVMs and hereditary hemorrhagic telangi-
ectasia.
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In most reported cases of PAVMs, the routine approach is
preventive transcatheter embolization to avoid complications.
These include neurologic sequelae (ie, stroke, transient ischemic
attack, cerebral abscess, and seizures) and, less commonly, pul-
monary hemorrhage, which could be fatal.3,4
In contrast to reported cases, our patient was treated in a
life-threatening situation. The large hemothorax, as well as the
previous medical history, prompted us to perform a CT scan to
investigate the presence of PAVM. As reported by Martinez and
associates,5 spontaneous hemothorax frequently occurs in patients
with disease-related coagulopathy or those receiving anticoagula-
tion treatment. Other causes include intrapleural bleeding compli-
cating pneumothorax (ie, disruption of pleural adhesions or torn
vascular adhesions), tuberculosis, sarcoidosis, pulmonary infarc-
tion, ruptured thoracic aneurysm, and subdiaphragmatic pathology
(endometriosis and pancreatic disease). The CT scan carried out on
our patient confirmed the presence of PAVMs.
Because the patient’s hemodynamic condition was stable, we
decided to perform a transcatheter embolization despite the pres-
ence of abundant pleural clots and hemothorax.
In our case the arteries entering the PAVMs were technically
suitable for coil occlusion, being long enough and not enlarged just
before entry into the aneurysms, without significant risk of the
coils entering the aneurysms and the draining veins. When feeding
arteries are short (3 cm), occlusion of the aneurysm might be
Figure 1. Thoracic CT scan showing left hemothorax and lobulated opacity in the left lower lobe with uptake of
contrast.
Figure 2. Pulmonary angiogram demonstrating PAVMs in the up-
per part of the left lower lobe (A) and in the lingula (B). The
diameter of the segmental feeding artery of the lingula fistula was
5 mm.
Figure 3. Pulmonary angiogram after embolization and complete
obliteration of PAVM.
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necessary.6 Detachable coils can be withdrawn if they are not
correctly sized or can be reinserted if not properly placed. How-
ever, some authors prefer to use detachable balloons.3
Supplying arteries with a diameter of 5 to 9 mm (approximately
70% of PAVMs) can be occluded equally well with either detach-
able silicone balloons or coils. Personal experience and preference
for a certain device will often be decisive in the choice of tech-
nique.7 Because anatomy can vary greatly, both detachable sili-
cone balloons and coils should be available as therapeutic options.4
After deployment of several coils in the feeding artery, flow is
reduced, and embolization can safely be achieved with glue, which
can shorten the procedure.
In most cases PAVMs are multiple, and more than one embo-
lotherapy session is required per patient. In a study reported by
White,6 276 PAVMs were diagnosed in 76 patients; all patients
had multiple malformations, and on average, 2 embolotherapy
sessions were necessary per patient in addition to diagnostic an-
giography, which was performed on a separate day. Embolo-
therapy sessions were separated by 4 to 6 weeks.
Current indications for transcatheter embolization include the
prevention of complications in larger (feeding artery diameter 3
mm) and symptomatic PAVMs. From our experience in cases of
massive hemoptysis-hemothorax, we believe occlusion of all ex-
isting PAVMs should be considered. This approach might have the
additional benefit of reducing the risk of paradoxical emboli and
other complications associated with unoccluded PAVMs.2 To our
knowledge, no data are currently available to predict which
PAVMs is most likely to rupture on the basis of size or location.
After embolization, different therapeutic options were avail-
able. A thoracic drainage procedure without surgical intervention
was an option; however, drainage efficiency could be hindered by
the presence of numerous clots. A surgical procedure to remove
clots and confirm the absence of bleeding was therefore considered
essential. Two surgical strategies were available. The first strategy
was a thoracotomy with local excision of all the PAVMs. This
technique, described by Bosher and colleagues,8 can be combined
with a previous embolization procedure.9 The feasibility of selec-
tive surgical resection depends on the PAVM localization, how-
ever, and lung tissue sparing is not always achievable. The second
option was to perform video-assisted surgery with wedge resection
of the PAVM, which could avoid the higher morbidity rates of
thoracotomy. This technique has been previously described by
Temes and associates10 but only for a solitary malformation. In our
case the PAVMs were multiple and not easily accessible for
video-assisted thoracoscopic resection. Because of a complete
absence of PAVM bleeding, we decided only to remove blood
clots.
As previously described by several authors,11,12 we observed a
recanalization of a PAVM 3 months later. Usually, occluded
PAVMs disappear or are reduced to a fibrous strand by the end of
1 year. Any evidence of persistence on CT suggests recanalization
(16% in the study of Ference and coworkers2) and is an indication
for re-embolization.3 Thereafter, follow-up thoracic CT scanning
is recommended every 3 to 5 years to investigate the possible
development of new PAVMs or growth of small PAVMs.3 Some
authors have proposed the use of 2-dimensional contrast echocar-
diography, with good results in detection and follow-up.13,14
All patients with hereditary hemorrhagic telangiectasia should
undergo routine screening for PAVM with noninvasive techniques,
preferably with the 100% oxygen method. Family members of
patients with hereditary hemorrhagic telangiectasia should also be
screened for PAVM.15
In our case a medical history of hereditary and recurrent epi-
staxis, as well as the presence of lip telangiectasia, was sufficient
to suspect ROW syndrome and screen for PAVMs, which are
associated with ROW in 60% to 90% of cases.16
Conclusion
Even in the presence of PAVM rupture, transcatheter embolization
could be performed. This procedure, combined with video-assisted
thoracoscopy, avoided lung tissue loss, preserved lung function,
and minimized morbidity. Because PAVMs can be recurrent,
minimally invasive treatment options are essential. Although re-
Figure 4. Thoracoscopic view showing the thrombosed PAVMs
on the left pulmonary surface: A, PAVM located in the upper part
of the left lower lobe; B, PAVM located in the lingula.
Figure 5. Follow-up thoracic CT scan 3 months after emboliza-
tion, showing partial recanalization of the lingula fistula.
Brief Communications
1206 The Journal of Thoracic and Cardiovascular Surgery ● October 2003
peated procedures might be required for persistent PAVMs or
recanalization, transcatheter embolization is a lung-sparing proce-
dure and should therefore always be considered in cases of PAVM.
We thank Mr Richard Medeiros and Miles Dalby for their
advice in editing the manuscript.
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Fatal air embolism during computed tomography– guided pulmonary
marking with a hook-type marker
Shoji Sakiyama, MD, PhD,a Kazuya Kondo, MD, PhD,a Hisashi Matsuoka, MD,a Mitsuteru Yoshida, MD,a
Takanori Miyoshi, MD, PhD,a Shusaku Yoshida, MD, PhD,b and Yasumasa Monden, MD, PhD,a Tokushima, Japan
Pulmonary marking with a hook wire, guided by com-puted tomography (CT), is often used to assist in theresection of small lung tumors that are difficult to iden-tify by means of thoracoscopic surgical techniques or
digital palpation. The most common complications accompanying
this procedure are pneumothorax, intrapulmonary hemorrhage, and
hemoptysis. These complications are usually mild, self-limiting,
and curable. Air embolism is a widely recognized complication of
transthoracic percutaneous needle biopsy, but in the case of CT-
guided pulmonary marking, few complications have been reported.
We report a case of fatal arterial gas embolism during hook wire
localization of a pulmonary lesion. The patient mortality was
mainly attributed to ischemic heart injury caused by air embolism.
Physicians should be aware of this possible complication when a
hook wire–type marker is used to avoid further fatalities.
Clinical Summary
A 79-year-old woman visited our hospital for an examination of a
2.0-cm abnormal shadow in the left upper lung field revealed by a
mass chest radiographic survey. A chest CT demonstrated a
1.5-cm tumor shadow with a faint density and ground-glass opac-
ity in S8 of the right lung in addition to a 2.0-cm tumor in S12 of
the left lung (Figure 1).
The patient was known to have had pulmonary tuberculosis in
her late twenties. She had no smoking history. Results of her
From the Departments of Oncological and Regenerative Surgerya and
Radiology,b School of Medicine, The University of Tokushima, To-
kushima, Japan.
Received for publication March 21, 2003; accepted for publication April 24,
2003.
Address for reprints: Shoji Sakiyama, MD, PhD, Department of Oncolog-
ical and Regenerative Surgery, School of Medicine, The University of
Tokushima, Kuramoto-cho 3, Tokushima 770-8503, Japan (E-mail:
sakiyama@clin.med.tokushima-u.ac.jp).
J Thorac Cardiovasc Surg 2003;126:1207-9
Copyright © 2003 by The American Association for Thoracic Surgery
0022-5223/2003 $30.00  0
doi:10.1016/S0022-5223(03)00821-3
Brief Communications
The Journal of Thoracic and Cardiovascular Surgery ● Volume 126, Number 4 1207
